Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization

Vaccine. 2001 Jun 14;19(27):3778-86. doi: 10.1016/s0264-410x(01)00090-1.

Abstract

Antigen specific immune responses were characterized after intramuscular immunization of BALB/c mice with 5 antigen encoding plasmid DNAs (pDNAs) complexed with Vaxfectin, a cationic lipid formulation. Vaxfectin increased IgG titers for all of the antigens with no effect on the CTL responses to the 2 antigens for which CTL assays were performed. Both antigen specific IgG1 and IgG2a were increased, although IgG2a remained greater than IgG1. Furthermore, Vaxfectin had no effect on IFN-gamma or IL-4 production by splenocytes re-stimulated with antigen, suggesting that the Th1 type responses typical of intramuscular pDNA immunization were not altered. Studies with IL-6 -/- mice suggest that the antibody enhancement is IL-6 dependent and results in a correlative increase in antigen specific antibody secreting cells.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Animals
  • Antibody Specificity / immunology*
  • Cytokines / biosynthesis
  • Drug Carriers
  • Ethanolamines*
  • Female
  • Immunity, Cellular / immunology
  • Immunoglobulin G / biosynthesis
  • Injections, Intramuscular
  • Interleukin-6 / deficiency
  • Interleukin-6 / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Myristic Acids*
  • Plasmids / administration & dosage
  • Plasmids / immunology*
  • Th1 Cells / immunology*

Substances

  • Adjuvants, Immunologic
  • Cytokines
  • Drug Carriers
  • Ethanolamines
  • Immunoglobulin G
  • Interleukin-6
  • Myristic Acids